Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma

This publication has 18 references indexed in Scilit:

• Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival
  Journal of Clinical Oncology, 2001
• Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients
  Laboratory Investigation, 2001
• Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
  JNCI Journal of the National Cancer Institute, 2000
• Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies
  British Journal of Haematology, 2000
• MethyLight: a high-throughput assay to measure DNA methylation
  Nucleic Acids Research, 2000
• Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease
  International Journal of Cancer, 1999
• High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease
  Journal of Medical Virology, 1999
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
  Gastroenterology, 1997
• Microsatellite alterations in plasma DNA of small cell lung cancer patients
  Nature Medicine, 1996
• Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong.
  Journal of Clinical Pathology, 1992